Typewritertx
Tokyo, JP · Founded 2022 · 1 known investors
Find your way into Typewritertx
Typewriter Therapeutics develops mRNA-based gene therapies using a platform for targeted insertion of therapeutic genes, building on transposon research from the University of Tokyo. It aims to treat patients with severe genetic disorders, with research facilities in Tokyo and Cambridge, USA.
Founders & leadership
Typewritertx was founded in 2022 by Jun Zhou, PhD, Haruhiko Fujiwara, PhD, Tom Eickbush, PhD, Kei Endo, PhD, and Jim Collins, PhD.
JZ
Jun Zhou, PhDFounder & Vice President, Discovery and Global Operations
HF
Haruhiko Fujiwara, PhDFounder & Advisor · Professor Emeritus, University of Tokyo
TE
Tom Eickbush, PhDCo-founder & Advisor · Professor Emeritus, University of Rochester
KE
Kei Endo, PhDCo-founder & Advisor · Associate Professor, University of Tokyo
JC
Jim Collins, PhDCo-founder & Advisor - Professor, MIT
MS
Matthew Stanton, PhDChief Executive Officer
Investors · 1
Frequently asked questions
- What does Typewritertx do?
- Typewriter Therapeutics develops mRNA-based gene therapies using a platform for targeted insertion of therapeutic genes, building on transposon research from the University of Tokyo. It aims to treat patients with severe genetic disorders, with research facilities in Tokyo and Cambridge, USA.
- Who founded Typewritertx?
- Typewritertx was founded by Jun Zhou, PhD, Haruhiko Fujiwara, PhD, Tom Eickbush, PhD, Kei Endo, PhD, Jim Collins, PhD in 2022.
- Who are Typewritertx's investors?
- Typewritertx's investors include AN Venture Partners.
- Where is Typewritertx headquartered?
- Typewritertx is headquartered in Tokyo, JP.